Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Adrafinil | Bacopa Monnieri | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication) | 300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands) |
| Timing | Early morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration. | With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects. |
| Cycle Duration | Short-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring. | Ongoing; benefits accumulate over months. No strict cycling required. |
| Evidence Level | moderate_human | strong_human |
Inactive prodrug that is hepatically metabolized to modafinil (via hepatic amidase enzymes) and its inactive acid metabolite modafinilic acid. The active metabolite modafinil then exerts its effects as a DAT inhibitor with downstream orexinergic, histaminergic, and noradrenergic activation. Conversion is incomplete — approximately 33-50% of adrafinil is converted to modafinil, with the remainder forming inactive metabolites. The hepatic first-pass metabolism means onset is delayed (60-90 minutes vs. 30-60 minutes for modafinil).
300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication)
Early morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration.
Short-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring.
Active triterpenoid saponins (bacosides A and B) provide multifaceted neuroprotection: inhibition of acetylcholinesterase (AChE) and activation of choline acetyltransferase (ChAT) to enhance cholinergic neurotransmission; upregulation of tryptophan hydroxylase and serotonin transporter expression to modulate serotonergic tone; antioxidant neuroprotection via induction of superoxide dismutase and glutathione peroxidase; and reduction of beta-amyloid aggregation. Additionally enhances GABA signaling through GABA-A receptor subunit upregulation and glutamate decarboxylase activation.
300-450 mg/day of standardized extract (24-55% bacosides, typically Bacognize or Synapsa brands)
With a fat-containing meal to improve absorption of fat-soluble bacosides. Morning or evening — some users report mild sedation. Minimum 8-12 weeks for full cognitive effects.
Ongoing; benefits accumulate over months. No strict cycling required.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →